KYMR logo

Kymera Therapeutics (KYMR) Retained earnings

annual retained earnings:

-$754.61M-$223.86M(-42.18%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual retained earnings is -$754.61 million, with the most recent change of -$223.86 million (-42.18%) on December 31, 2024.
  • During the last 3 years, KYMR annual retained earnings has fallen by -$525.63 million (-229.55%).
  • KYMR annual retained earnings is now -2043.17% below its all-time high of -$35.21 million, reached on December 31, 2018.

Performance

KYMR Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

quarterly retained earnings:

-$820.19M-$65.58M(-8.69%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly retained earnings is -$820.19 million, with the most recent change of -$65.58 million (-8.69%) on March 31, 2025.
  • Over the past year, KYMR quarterly retained earnings has dropped by -$240.88 million (-41.58%).
  • KYMR quarterly retained earnings is now -972.76% below its all-time high of -$76.46 million, reached on December 31, 2019.

Performance

KYMR quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

KYMR Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-42.2%-41.6%
3 y3 years-229.6%-208.7%
5 y5 years-887.0%-

KYMR Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-229.6%at low-168.1%at low
5 y5-year-887.0%at low-658.8%at low
alltimeall time-2043.2%at low-972.8%at low

KYMR Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$820.19M(+8.7%)
Dec 2024
-$754.61M(+42.2%)
-$754.61M(+10.3%)
Sep 2024
-
-$683.86M(+10.1%)
Jun 2024
-
-$621.37M(+7.3%)
Mar 2024
-
-$579.31M(+9.1%)
Dec 2023
-$530.75M(+38.3%)
-$530.75M(+2.8%)
Sep 2023
-
-$516.38M(+11.4%)
Jun 2023
-
-$463.52M(+9.1%)
Mar 2023
-
-$424.72M(+10.7%)
Dec 2022
-$383.79M
-$383.79M(+10.0%)
Sep 2022
-
-$348.93M(+14.1%)
DateAnnualQuarterly
Jun 2022
-
-$305.92M(+15.2%)
Mar 2022
-
-$265.67M(+16.0%)
Dec 2021
-$228.98M(+77.8%)
-$228.98M(+17.4%)
Sep 2021
-
-$195.08M(+17.2%)
Jun 2021
-
-$166.50M(+17.4%)
Mar 2021
-
-$141.84M(+10.2%)
Dec 2020
-$128.76M(+68.4%)
-$128.76M(+10.9%)
Sep 2020
-
-$116.08M(+7.4%)
Jun 2020
-
-$108.09M(+41.4%)
Dec 2019
-$76.46M(+117.1%)
-$76.46M
Dec 2018
-$35.21M
-

FAQ

  • What is Kymera Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Kymera Therapeutics?
  • What is Kymera Therapeutics annual retained earnings year-on-year change?
  • What is Kymera Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly retained earnings year-on-year change?

What is Kymera Therapeutics annual retained earnings?

The current annual retained earnings of KYMR is -$754.61M

What is the all time high annual retained earnings for Kymera Therapeutics?

Kymera Therapeutics all-time high annual retained earnings is -$35.21M

What is Kymera Therapeutics annual retained earnings year-on-year change?

Over the past year, KYMR annual retained earnings has changed by -$223.86M (-42.18%)

What is Kymera Therapeutics quarterly retained earnings?

The current quarterly retained earnings of KYMR is -$820.19M

What is the all time high quarterly retained earnings for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly retained earnings is -$76.46M

What is Kymera Therapeutics quarterly retained earnings year-on-year change?

Over the past year, KYMR quarterly retained earnings has changed by -$240.88M (-41.58%)
On this page